Effects of platelet membrane glycoprotein polymorphisms on the risk of myocardial infarction in young males

Israel Medical Association Journal

Volumn 4, Issue 6, 2002, Pages 411-414

  Rosenberg, Nurit ^a   Zivelin, Ariella ^a   Chetrit, Angela ^a   Dardik, Rima ^a   Kornbrot, Nurit ^a   Freimark, Dov ^a   Inbal, Aida ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

GPIa; GPIb; GPIIIa; Myocardial infarction; Platelet polymorphisms

Indexed keywords

HEALTH RISKS; METABOLISM; PROTEINS;

PLATELETS; POLYMORPHISMS;

BIOMEDICAL ENGINEERING;

ALPHA2 INTEGRIN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IIIA; THROMBOCYTE ANTIGEN; THROMBOCYTE ANTIGEN 1A; THROMBOCYTE ANTIGEN 1B; THROMBOCYTE ANTIGEN 2A; THROMBOCYTE ANTIGEN 2B; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROTEIN POLYMORPHISM; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0036285134     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
2. Coronary thrombosis in myocardial infarction: Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction
3. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelets spreading
4. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
5. Integrin polymorphisms as risk factors for thrombosis
6. Hereditary variation in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence
7. Nucleotide polymorphisms in the α2 gene define multiple alleles that are associated with differences in platelet α2β1 density
8. Platelet antigen polymorphisms
9. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
10. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness
11. The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145
12. Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex
13. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
14. The cardiovascular health study: Design and rationale
15. A simple salting out procedure of extracting DNA from human nucleated cells
16. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis
17. A2 and coronary risk: A meta-analysis
18. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease
19. 1648G gene polymorphism is associated with the risk and extent of coronary artery disease in low risk patients
20. β3-integrin-deficient mice are not protected from developing intimal hyperplasia after vascular injury
21. IIbβ3 (GPIIB/IIIa) and αvβ3 receptors are not protected from atherosclerosis
22. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
23. A2) is an inherited risk factor for myocardial infarction and death